Full Text View
Tabular View
No Study Results Posted
Related Studies
Prognostic Value of Hyperexcitability of the Central Hypersensitivity in Patients With Acute Low Back Pain
This study is currently recruiting participants.
Verified by University Hospital Inselspital, Berne, May 2009
First Received: May 1, 2009   No Changes Posted
Sponsored by: University Hospital Inselspital, Berne
Information provided by: University Hospital Inselspital, Berne
ClinicalTrials.gov Identifier: NCT00892411
  Purpose

Background. Patients with chronic low back pain display hyperexcitability of the central nervous system (central hypersensitivity). Such hypersensitivity may occur in the acute phase and represent a risk factor for the development of chronic pain.

Objective. To determine the prognostic value of central hypersensitivity for the development of chronic low back pain.

Design. Prospective cohort study.

Setting. Primary care.

Patients. 140 individuals with acute low back pain and no history of chronic pain.

Outcomes. Primary prognostic variable will be the pain tolerance threshold at the second toe (the pressure intensity at which a further increase in pressure is deemed intolerable). Exploratory secondary prognostic variables are measures of mechanisms related to central hypersensitivity: stimulus-specific hypersensitivity (pressure, electrical, heat and cold stimulation); tissue-specific hypersensitivity (skin vs. muscle stimulation); localized vs. widespread hypersensitivity; spinal cord modulation (electrophysiological measures of hypersensitivity and changes in receptive fields); modulation at brain level (descending modulation of nociceptive input and cortical plasticity). Clinical primary outcome will be the occurrence of chronic low back pain at follow-up.

Main analysis. The investigators will use least square logistic regression models to determine the association of central hypersensitivity with prognosis.

Relevance. An understanding of the prognostic value of central hypersensitivity may allow an early stratification for treatment of individuals at risk of developing chronic low back pain. Subgroups of patients may be selected for clinical trials on novel pharmacological approaches for the prevention and treatment of central hypersensitivity.


Condition Intervention
Pain Measurement
Low Back Pain
Other: Assessment of parameters of central hypersensitivity
Other: Spinal cord hyperexcitability
Other: Descending modulation and cortical reorganization

MedlinePlus related topics: Allergy Back Pain
U.S. FDA Resources
Study Type: Observational
Study Design: Cohort, Prospective
Official Title: Prognostic Value of Measures of Central Hypersensitivity in Patients With Low Back Pain

Further study details as provided by University Hospital Inselspital, Berne:

Primary Outcome Measures:
  • Presence or absence of chronic low back pain [ Time Frame: 6 months after the acute episode ] [ Designated as safety issue: No ]

Secondary Outcome Measures:
  • Mechanisms of central hypersensitivity [ Time Frame: During the acute episode of low back pain ] [ Designated as safety issue: No ]

Estimated Enrollment: 140
Study Start Date: February 2009
Estimated Study Completion Date: December 2010
Estimated Primary Completion Date: December 2010 (Final data collection date for primary outcome measure)
Groups/Cohorts Assigned Interventions
1
Evaluation of spinal cord hyperexcitability, temporal summation and spinal reorganization
Other: Assessment of parameters of central hypersensitivity
Sensory tests, pain thresholds, nociceptive reflexes, EEG.
2
Evaluation of descending modulation and cortical reorganization
Other: Spinal cord hyperexcitability
Sensory tests and spinal reflexes
Other: Descending modulation and cortical reorganization
Sensory tests and EEG.

Detailed Description:

Background

Prolonged afferent nociceptive input induces an increase in the excitability of central sensory neurons and plasticity changes that cause hyperexcitability of the central nervous system (central hypersensitivity. The hyperexcitable central nervous system amplifies the nociceptive signal, thereby producing an exaggerated pain response even in the presence of limited tissue damage.

Using quantitative sensory tests, central hypersensitivity has been detected in different chronic musculoskeletal pain syndromes. Patients with chronic low back pain display increased pain sensitivity and enlargement of the areas of referred pain after stimulation of tissues around and distant from the site of pain (i.e. the leg or the thumb), suggesting that widespread central hypersensitivity is associated with this condition. Functional reorganization of the cortex has been detected in different pain conditions, including low back pain. Using equal levels of sensory stimulation in patients and pain-free controls, patients with chronic low back pain showed more extensive patterns of neuronal activation in pain-related cortical areas. An investigation on patients after a whiplash injury found that those patients with persistent moderate or severe symptoms at 6 months had displayed, soon after injury, widespread hypersensitivity. Therefore, central hypersensitivity may be an indicator of poor prognosis. An acute peripheral lesion may induce plasticity changes leading to central hypersensitivity in a subset of individuals. Such a hypersensitivity would facilitate the transition from acute to chronic pain and disability. This hypothesis has been investigated using a limited number of tests only in a limited number of individuals with whiplash injury, but not in any other condition.

Objective

To determine the prognostic value of different measures of mechanisms of central hypersensitivity in patients with acute low back pain.

Methods

140 consecutive Patients with acute low back pain, referred by general practice, will be studied prospectively. Primary prognostic variable will be the pain tolerance threshold at the second toe (the pressure intensity at which a further increase in pressure is deemed intolerable). Exploratory secondary prognostic variables are measures of mechanisms related to central hypersensitivity: stimulus-specific hypersensitivity (pressure, electrical, heat and cold stimulation); tissue-specific hypersensitivity (skin vs. muscle stimulation); localized vs. widespread hypersensitivity; spinal cord modulation (electrophysiological measures of hypersensitivity and changes in receptive fields); modulation at brain level (descending modulation of nociceptive input and cortical plasticity). Clinical primary outcome will be the occurrence of chronic low back pain at follow-up. We will use least square logistic regression models to determine the association of central hypersensitivity with prognosis.

  Eligibility

Ages Eligible for Study:   18 Years to 80 Years
Genders Eligible for Study:   Both
Accepts Healthy Volunteers:   No
Sampling Method:   Probability Sample
Study Population

Patients with acute low back pain referred from primary care.

Criteria

Inclusion Criteria:

  • Acute low back pain < 6 weeks
  • Age 18-80

Exclusion Criteria

  • History of chronic low back pain
  • Radicular pain
  • Pregnancy
  • Breast feeding
  Contacts and Locations
Please refer to this study by its ClinicalTrials.gov identifier: NCT00892411

Contacts
Contact: Alban Neziri 0041-31-632 1245 alban.neziri@insel.ch

Locations
Switzerland
Dep. of Anesthesiology and Pain Therapy, Bern University Hospital Recruiting
Bern, Switzerland, 3010
Contact: Curatolo     0041-31-632 0133     michele.curatolo@insel.ch    
Principal Investigator: Neziri            
Sponsors and Collaborators
University Hospital Inselspital, Berne
Investigators
Study Director: Michele Curatolo Dep. of Anesthesiology and Pain Therapy, Bern University Hospital
Principal Investigator: Neziri Dep. of Anesthesiology and Pain Therapy, Bern University Hospital
  More Information

No publications provided

Responsible Party: Inslspital, Bern University Hospital, Bern, Switzerland ( Michele Curatolo / Principal Investigator )
Study ID Numbers: KEK 103/08
Study First Received: May 1, 2009
Last Updated: May 1, 2009
ClinicalTrials.gov Identifier: NCT00892411     History of Changes
Health Authority: Switzerland: Ethikkommission

Keywords provided by University Hospital Inselspital, Berne:
Neuroplasticity
Prognosis

Study placed in the following topic categories:
Signs and Symptoms
Hypersensitivity
Neurologic Manifestations
Low Back Pain
Pain
Back Pain

Additional relevant MeSH terms:
Signs and Symptoms
Hypersensitivity
Immune System Diseases
Nervous System Diseases
Neurologic Manifestations
Low Back Pain
Pain
Back Pain

ClinicalTrials.gov processed this record on May 07, 2009